Home
Search
Search Results
Previously Searched
3199 results found
Expand All
Apply All
3199 results found

Letter to House and Senate Judiciary Committee Leadership on FTC-DOJ Regulation of Mergers
Letters, Testimony & Comments  •  November 14, 2023
BIO joins 30 other national trade associations in speaking out against unprecedented and burdensome FTC-DOJ regulation of mergers
Read More

Stakeholder Letter on PAHPA Reauthorization
Vaccines  •  Letters, Testimony & Comments  •  November 14, 2023
BIO joined other stakeholders to urge Congressional leaders to reauthorize the Pandemic and All-Hazards Preparedness Act (PAHPA).
Read More

General Events Sign Up Page

Desperate to stop a drug-resistant infection
Bio.News  •  November 14, 2023
After contracting a drug-resistant infection that wouldn’t go away, a patient developed his own wound dressing—but why would he need to do this? The I am BIO Podcast explores Bradley Burnam’s story, and the state of the antimicrobials market. Plus, BIO launches a powerful new resource for early-stage biotech companies. (576 words, 2 minutes, 52 seconds)
Read More

Climate Policy Innovation Series: Food and Agriculture Systems
Webinars  •  November 14, 2023
View this conversation highlighting how BIO member companies are strengthening food security and addressing climate change through biotechnology innovations in crop protection and efficient food production. Learn how regulation and policy can support agricultural innovation to protect our environment and our food supply.
Read More
Food and Farm Innovation

“On My Own”—Desperate to Stop a Resistant Bacterial Infection
I am BIO Podcast  •  November 14, 2023
Bradley Burnam woke up one morning, looked in the mirror and found one ear twice it’s normal size and his face swollen and discolored. He would spend the next several years in and out of the hospital fighting a relentless infection that would not respond to available treatments. The experience took him from patient to "mad scientist" to biotech company founder. In this episode, Bradley takes us through his desperate journey to find a cure. We also talk with the leader of an organization helping to get more antimicrobials to the marketplace.
Read More
“On My Own”—Desperate to Stop a Resistant Bacterial Infection

World's first chikungunya vaccine
Bio.News  •  November 13, 2023
While a potential government shutdown looms, we’re looking at exciting biotech innovations—from the world’s first vaccine for chikungunya virus, to promising treatments for a range of cardiovascular diseases. (465 words, 2 minutes, 19 seconds)
Read More

BIO and BIO member Letter to Congressional Leadership on the Medical Countermeasures (MCM) Priority Review Voucher (PRV) program
Letters, Testimony & Comments  •  November 10, 2023
BIO and BIO members are urging lawmakers to enact a short-term extension of the MCM-PRV program while Congress is waiting to address a full reauthorization with PAHPA.
Read More

Opposing CMS rule, advancing SAF
Bio.News  •  November 10, 2023
Members of Congress joined the chorus against CMS’ proposed rule on the Medicaid Drug Rebate Program, and several U.S. Representatives introduced a bill to advance SAF. Ahead of Veterans Day, we look at how biotech—including BIO’s vice chair—is recognizing and supporting veterans. (684 words, 3 minutes, 25 seconds)  
Read More

How you can take action on PBMs
Bio.News  •  November 9, 2023
The Senate Finance Committee advanced critically important PBM transparency legislation—here’s what happened and how you can take action. Plus, BIO joined 45+ organizations in condemning the Biden administration’s recent decision on international data flows. (703 words, 3 minutes, 30 seconds)
Read More